Moshe Weinstein

Rad Biomed Accelerator Ltd. (Rad Biomed Accelerator) is a venture capital subsidiary of RAD-Bynet Group founded by Yehuda Zisapel and Nava Zisapel in 1992. The firm is headquartered in Tel Aviv, Israel.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel.

Cody Genetics Ltd. is a British animal biotechnology company that applies gene-editing technology to benefit animal farming. Cody Genetics is based in Edinburgh, UK and was founded in 2022 by Yaniv Dolev, who has been the CEO since inception, and Glen Illing, who is the founder and chairman. The company is committed to becoming a leader in the farm animal gene-editing industry through its collaborations with leading academic and industry research institutes. The company's first product is sex-biasing in farm animals, which increases profitability, quadruples semen yield, lowers costs 20x +, increases successful inseminations, decreases production waste and environmental impact, eliminates culling of 3.5b male chicks, reduces breeding hens by 50%, and eliminates swine castration while improving efficiency of production. Cody Genetics is currently raising capital and has partnered with industry leaders.

Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception.

Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA.

Lipocure Ltd. develops nano-drugs based on liposomes. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Yechezkel Barenholz.

Power Paper Ltd. develops and manufactures printed energy cells. It specializes in the design, creation, and licensing of printable batteries. The company was founded by Zvi Nitzan and Barush Levanon in 1997 and is headquartered in Beit Shemesh, Israel.

Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel.

BELKIN Vision Ltd. provides glaucoma laser treatment. The company was founded by Michael Belkin in 2013 and is headquartered in Tel Aviv, Israel.

MigVax Ltd. manufactures vaccines that provide immunological, mucosal, blood-based, and cell-mediated immunity. The company is based in Hazafon, Israel. The CEO of the Israeli company is David Zigdon.

Synvaccine Ltd. engages in designing and fabricating designer viruses for biotechnology. It specializes in platform technology combining cutting edge technologies including synthetic biology, virology, bio-informatics, engineering and robotics. The company was founded by Tamir Tuller and Tuval Benyehezkel in 2013 and is headquartered in Tel Avib, Israel.

Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA.

Vectorious Medical Technologies Ltd. develops cardiac monitoring system for patients suffering from congestive heart failure. Its system implements a novel approach to long-term, implant-based hemodynamic monitoring that leverages state-of-the-art technologies in the areas of miniature sensing and wireless communications. The company was founded in November by Oren Goldshtein, Eyal Orion and Ronny Winstein 2011 and is headquartered in Tel Aviv, Israel.